BREAKING
Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 2 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 3 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 6 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 8 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 9 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 12 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 13 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 14 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 15 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 16 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 2 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 3 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 6 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 8 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 9 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 12 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 13 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 14 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 15 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 16 hours ago
ADVERTISEMENT
Market News

Earnings Summary: Dentsply Sirona reports higher sales for Q4 2023

Dentsply Sirona Inc. (NASDAQ: XRAY), a leading manufacturer of professional dental products and technologies, reported fourth-quarter 2023 financial results, reporting an increase in net sales. Fourth-quarter net sales increased 2.9% year-over-year to $1.01 billion; organic sales moved up1.9% Net income, including special items, was $67 million or $0.32 per share in Q4, vs. a loss […]

February 29, 2024 1 min read

Dentsply Sirona Inc. (NASDAQ: XRAY), a leading manufacturer of professional dental products and technologies, reported fourth-quarter 2023 financial results, reporting an increase in net sales.

  • Fourth-quarter net sales increased 2.9% year-over-year to $1.01 billion; organic sales moved up1.9%
  • Net income, including special items, was $67 million or $0.32 per share in Q4, vs. a loss of $15 million or $0.07 per share a year earlier
  • On an adjusted basis, the company reported earnings of $0.44 per share, down from the $0.46 per share it reported a year earlier
  • For fiscal 2024, the company expects organic sales to be flat to up 1.5%; adjusted EPS is expected to be between $2.00 and $2.10
  • The board of directors approved a 14% increase in the company’s quarterly dividend rate, from the previous rate of $0.14 per share
ADVERTISEMENT